MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Sex differences in prodromal Parkinson’s disease (PD)

    K. Atterling Brolin, S. Waters, H. Chohan, B. Huxford, S. Meyer, L. Smith, A. Shahid, A. Kuri, J. Bestwick, R. Benabderrazik, R. Lathey, E. Pablo Fernandez, L. Pérez-Carbonell, C. Simonet, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To explore sex-specific differences in symptoms of prodromal Parkinson's in the PREDICT-PD cohort Background: Multiple lines of evidence suggest that biological sex is an…
  • 2025 International Congress

    Exploring expectation bias in Parkinson’s disease clinical trials by comparing placebo arm progression on MDS-UPDRS to a natural history dataset

    M. Potashman, L. Powell, B. Rogula, F. Nagase, C. de Brun, V. Coric, J. Dubow, L. Rosenthal, G. L'Italien (New Haven, USA)

    Objective: To examine baseline characteristics and disease progression of newly diagnosed Parkinson’s disease (PD) patients enrolled in clinical trials vs natural history. Background: Differences in…
  • 2025 International Congress

    Impact of parkinson’s disease on work disability: a cross-sectional study

    S. Secades, C. Martin (Madrid, Spain)

    Objective: To evaluate the impact of Parkinson’s disease (PD) on work disability and identify clinical and demographic factors associated with occupational impairment. Additionally, this study…
  • 2025 International Congress

    Neuroprotective Effects of ATP6V0C Overexpression in PFF Model Mice

    Y. Wang, Y. Xia, L. Kou, T. Wang (wuhan, China)

    Objective: Elucidating the role of lysosomal dysfunction due to altered stability and expression levels of V-type proton subunit ATP6V0C in the degradation and propagation of…
  • 2025 International Congress

    Impaired Speech Perception in Noise (SPiN), Hearing Loss, and Cholinergic Denervation in Parkinson’s Disease

    S. Roytman, D. Mccaslin, J. Barr, R. Vangel, P. Kanel, N. Bohnen (Ann. Arbor, USA)

    Objective: This study will investigate the relationships among speech-perception-in-noise (SPiN), hearing acuity, and cholinergic system changes in patients with PD. Background: Recent studies highlight a…
  • 2025 International Congress

    Fatty Acid Metabolic Reprogramming Regulates Glial-Epithelial Axis via Nur77 Palmitoylation in Intestinal Dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, Z. Lu, X. Luo, F. Yu, W. Bi (Guangzhou, China)

    Objective: This study aims to elucidate the regulatory role of stearoyl-CoA desaturase 1 (SCD1) in Parkinson’s disease (PD)-associated intestinal dysfunction, focusing on its mechanism in…
  • 2025 International Congress

    Transcranial sonography in Parkinson’s disease patients

    D. Khasanova, I. Khasanov, Z. Zalyalova (Kazan, Russian Federation)

    Objective: To present the usage and results of transcranial sonography (TCS) in Parkinson's disease (PD) patients. Background: (TCS) has emerged as a valuable diagnostic tool…
  • 2025 International Congress

    Exploring local gyrification index to understand Parkinson’s disease with mild cognitive impairment

    N. Chaurasiya, A. Katragadda, G. Rathi, J. Caldwell, Z. Mari, V. Mishra (Birmingham, USA)

    Objective: To investigate correlations between local gyrification index (LGI) and neuropsychological variables in participants with Parkinson's disease (PD) experiencing mild cognitive impairment (PD-MCI). Background: PD…
  • 2025 International Congress

    Cholinergic activity associates with cognitive function in PD using [18F]VAT

    J. O'Donnell, A. Eid, H. Hwang, S. Grossen, J. Hood, E. Foster, Z. Tu, J. Perlmutter, M. Campbell (St. Louis, USA)

    Objective: To map the relationship between cholinergic activity in Parkinson Disease (PD) and cognitive performance and identify any differences in this relationship in cognitive impairment.…
  • 2025 International Congress

    Sex-Dependent Associations Between PGLYRP2 Variants and Parkinson’s Disease Across Diverse Ancestries

    HM. Chaparro-Solano, CL. Avila, V. Quintana-Peña, KA. Brolin (Cleveland, USA)

    Objective: To investigate the association between PGLYRP2 polymorphisms and Parkinson’s disease (PD) across diverse ancestral populations. Background: Emerging evidence suggests a role of the gastrointestinal…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley